| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |